| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AC05) | ustekinumab; parenteral | 766 | |
| PURCH | PURCH_ATC(L04AC10) | secukinumab; parenteral | 726 | |
| PURCH | PURCH_ATC(L04AC13) | ixekizumab; parenteral | 446 | |
| PURCH | PURCH_ATC(L04AC07) | tocilizumab; parenteral | 444 | |
| PURCH | PURCH_ATC(L04AC16) | guselkumab; systemic | 296 | |
| PURCH | PURCH_ATC(L04AC18) | risankizumab; parenteral | 283 | |
| PURCH | PURCH_ATC(L04AC14) | sarilumab; systemic | 172 | |
| PURCH | PURCH_ATC(L04AC21) | bimekizumab; systemic | 82 | |
| PURCH | PURCH_ATC(L04AC03) | anakinra; parenteral | 45 | |
| PURCH | PURCH_ATC(L04AC12) | brodalumab; systemic | 11 |